Drug Trial Radar · NCT07687966
CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic Surgery
Last checked: Nov 19, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
May 8, 2026
Primary completion
Jun 30, 2026
Study completion Sep 30, 2026
Sponsor
- Lead sponsor
- Clarent Biopharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Randomized, double-blind, clinical study to evaluate the safety and efficacy of CBP-0276 at doses of 600 mg/day in reducing opioid use in pain management in adult patients undergoing major orthopedic surgery. Subjects will be allocated in 2 groups. One group will receive oxycodone (standard of care) + CBP-0276 at a dose of 600 mg, orally once daily for 28 days. A second group will receive oxycodone (standard of care) + placebo for CBP-0276, orally once daily for 28 days
Conditions
- Hip or Knee Replacement
Interventions
CBP-0276Drug
Oxycodone CBP-0276 orally 600mg QD, orally once a day for 30 days
Placebo for CBP-0276Drug
Oxycodone (standard of care) + placebo for CBP-0276, orally once daily for 30 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of oxycodone useTime frame: 28 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Innovacion y Desarrollo de Estrategias en Salud
Mexico City, Mexico · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.